Dose reduction of biological therapies for inflammatory rheumatic diseases: what do patients think?

被引：10
|
作者：
Wallis, D. [1 ]
Holmes, C. [1 ]
Holroyd, C. [1 ]
Sonpal, K. [2 ]
Zarroug, J. [2 ]
Adams, J. [3 ]
Edwards, C. J. [1 ,2 ]
机构：
[1] Univ Hosp Southampton NHS Fdn Trust, Rheumatol Dept, Southampton, Hants, England
[2] Univ Hosp Southampton, NIHR Southampton Clin Res Facil, Southampton, Hants, England
[3] Univ Southampton, Ctr Innovat & Leadership Hlth Sci, Southampton, Hants, England
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2019年 / 48卷 / 03期
关键词：
ARTHRITIS;
D O I：
10.1080/03009742.2018.1533034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：251 / 252
页数：2
相关论文
共 50 条
  • [1] TAPERING BIOLOGICAL THERAPIES: WHAT DO PATIENTS THINK?
    Holmes, Claire
    Wallis, Dinny
    Holroyd, Christopher
    Sonpal, Kate
    Zarroug, Jalaa
    Adams, Jo
    Edwards, Christopher J.
    [J]. RHEUMATOLOGY, 2018, 57
  • [2] REAL LIFE DOSE REDUCTION OF BIOLOGICAL THERAPY IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES. UTILITY OF THE REDOSER TOOL
    Arija, S. Manrique
    Cabezas-Lucena, A. M.
    Godoy-Navarrete, F.
    Morales-Aguila, M.
    Redondo, R.
    Mena-Vazquez, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1502 - 1502
  • [3] Biological therapies in rheumatic diseases
    Conti, F.
    Ceccarelli, F.
    Massaro, L.
    Cipriano, E.
    Di Franco, M.
    Alessandri, C.
    Spinelli, F. R.
    Scrivo, R.
    Valesini, G.
    [J]. CLINICA TERAPEUTICA, 2013, 164 (05): : E413 - E428
  • [4] WHAT DO PATIENTS THINK ABOUT THE IDEA OF BIOLOGIC DOSE REDUCTION AND WHAT INFORMATION DO PATIENTS NEED TO MAKE DECISIONS ABOUT DOSE REDUCTION?
    Haig-Ferguson, Andrew
    [J]. RHEUMATOLOGY, 2018, 57
  • [5] Adherence to subcutaneous biological therapies in patients with inflammatory rheumatic diseases and inflammatory bowel disease: a systematic review
    Nieto, Juan C.
    Arajol, Claudia
    Carmona, Loreto
    Marras, Carlos
    Cea-Calvo, Luis
    [J]. IMMUNOTHERAPY, 2021, 13 (05) : 433 - 458
  • [6] DIETARY PRACTICE AND CHRONIC INFLAMMATORY RHEUMATIC DISEASES. WHAT DO OUR PATIENTS?
    Labrousse, M.
    Alleyrat, C.
    Gervais, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 2104 - 2105
  • [7] The risks of biological and immunosuppressant therapies in pregnant patients with rheumatic diseases
    Cervera, R
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 5 - 5
  • [8] THE BURDEN OF HOSPITALISED INFECTION IN PATIENTS ON BIOLOGICAL THERAPIES FOR RHEUMATIC DISEASES
    Chou, L.
    Day, J.
    Tacey, M.
    O'Neill, C.
    Junek, M.
    Wicks, I
    Van Doornum, S.
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 : 14 - 14
  • [9] ECONOMIC EVALUATION OF BIOLOGICAL THERAPIES IN RHEUMATIC DISEASES
    Gomez Gomez, D.
    Colon Lopez de Dicastillo, A.
    Ochagavia Sufrategui, M.
    de las Revillas Almajano, F. Arnaiz
    Valero Dominguez, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1211 - 1211
  • [10] RECENT ADVANCES IN BIOLOGICAL THERAPIES IN RHEUMATIC DISEASES
    Robinson, P.
    [J]. INTERNAL MEDICINE JOURNAL, 2012, 42 : 11 - 11
12345